US 8569340
AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the same
granted A61PA61P3/00A61P3/06
Quick answer
US patent 8569340 (AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the same) held by Rigel Pharmaceuticals, Inc. expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P3/00, A61P3/06, A61P3/08, A61P3/10